Neoadjuvant Imlunestrant Plus Abemaciclib Treatment Guided by Ki67 Index After 2 Weeks for ER-Positive HER2-Negative Breast Cancer

​ Conditions: Breast Cancer

Interventions: Drug: Imlunestrant + abemaciclib; Drug: (dd)EC*4-T*4

Sponsors: Fudan University

Not yet recruiting Conditions: Breast Cancer
Interventions: Drug: Imlunestrant + abemaciclib; Drug: (dd)EC*4-T*4
Sponsors: Fudan University
Not yet recruiting